plasma 6-0x0 PGF,, described. Human plasma levels of 6-0x0 PGF,, were reported to remain unchanged throughout pregnancy and were no different when compared with those of a group of non-pregnant women (Ylikorkala & Viinikka. 198 1) ; however, increased levels were observed in cancer patients with solid tumours (Demers & Derck, 1980) . The wide range of values reported for human plasma 6-0x0 PGF , , levels makes comparison between normal and diseased groups difficult. The significance of clinical studies is questionable when the variation in plasma 6-0x0 PGF,, levels of 'normal' volunteer groups is frequently greater than the difference observed between 'diseased' and 'control' groups (see references above). These observations may in part be due to the different procedures for the measurement of prostacyclin. for example by bioassay, and the determination of 6-0x0 PGF In by radioimmunoassay. Furthermore. extraction procedures have been used in the radioimmunoassay of 6-0x0 PGF,, when the specificity and sensitivity of the antisera appear otherwise suitable for the direct measurement of plasma 6-0x0 PGF,, (see. e.g., Mitchell, 1978) . A further complication arises from the uncertainty surrounding the transformation of prostacyclin to 6-0x0 PGF,, and as to whether this is the exclusive pathway of prostacyclin transformation and metabolism. For example. evidence has been presented implicating 6-0x0 PGE, as a major product of prostacyclin metabolism in whole blood (Wong et a/.. 1980) . To investigate these problems further. we developed two radioimmunoassays for the measurement of 6-0x0 PGF , , and alleged plasma metabolites of prostacyclin. Antisera were raised in rabbits by immunization with a 6-0x0 PGF,,-bovine serum albumin conjugate prepared as described by Dray et a/. (1975).
The first antiserum reacted almost exclusively with 6-0x0 PGF,, (of 19 prostaglandins examined) and the second cross-reacted lOoO/o with 6-0x0 PGF,,, 13,14-dihydro-6-oxo PGF,,. 13.14-dihydro-6.15-dioxo PGF,,, 6-0x0 PGE, and 50% with 13.14-dihydro PGF,,. Direct measurement of immunoreactive 6-0x0 PGF,, in human plasma using the first antiserum resulted in levels generally less than I0pg.ml-I. In a study of normal volunteers who by declaration had not taken non-steroidal anti-inflammatory drugs in the 10 days before venepuncture, immunoreactive 6-ox0 PGF,, levels were 6.1 & 0.6pg. ml-l (mean f s.E.M.. n = 38: range 0-1 2.5 pg . ml-I). In some cases plasma 6-0x0 PGF,, was below the limit of detection of the radioimmunoassay (0.5 pg least-detectable mass). In a smaller study. a group of normal males had peripheral venous plasma 6-0x0 PGF,, levels of 7.1 f0.6pg.ml-l (mean S.E.M. n = 12) and females 6.8 f 0.7 (mean f S.E.M. n = 8) and indicated that there were no sex differences in plasma levels of 6-0x0 PGF,,.
Additional studies with a second antiserum that cross-reacted with metabolites of prostacyclin resulted in similar levels of immunoreactive 6-0x0 PGF,, equivalents in plasma. These findings support the view that the immunoreactivity measured in human plasma was due to 6-0x0 PGF,, and not one of the cross-reacting metabolites in the second radioimmunoassay. In view of these low values for plasma 6-0x0 PGFl0, a closer examination of the radioimmunoassay conditions was undertaken. Measurement of assay parameters revealed that nonspecific binding due to plasma could not be displaced by an excess (lng) of 6-0x0 PGFIa and did not interfere with the direct assay procedure. In cases where 6-0x0 PGFl0 immunoreactivity caused greater than 20% displacement of ligand, serial dilution indicated a linear relationship. Addition of known quantities of authentic prostacyclin and 6-0x0 PGF,, to human citrated plasma at concentrations at the lower end of the 'normal' range previously described (see references above) resulted in quantitative recovery of immunoreactivity with both antisera. These findings confirmed that the radioimmunoassays were sensitive enough to detect low levels of plasma 6-0x0 PGF,, and, furthermore, that prostacyclin was quantitatively transformed to immunoreactive 6-0x0 PGF,,. It was concluded from these studies that the levels of 6-0x0 PGF,,. 13.14-dihydro-6-0x0 PGF,,, 13,14-dihydro-6.15-dioxo PGF , , and 6-0x0 PGE, in human peripheral venous plasma were lower than reported elsewhere and that normal venous plasma contained less than IOpg. ml-' of these metabolites.
